Effect of Lactobacillus Reuteri on the Proliferation of Propionibacterium Acnes and Staphylococcus Epidermidis

Overview

Journal J Microbiol

Specialty Microbiology

Date 2012 Feb 28

PMID 22367948

Citations 8

Authors

Mi-Sun Kang

Jong-Suk Oh

Seok-Woo Lee

Hoi-Soon Lim

Nam-Ki Choi

Seon-Mi Kim

Affiliations

Soon will be listed here.

Abstract

While it is generally accepted that Propionibacterium acnes is involved in the development of acne, other bacteria including Staphylococcus epidermidis have also been isolated from the acne lesion. The interaction between Lactobacillus reuteri, a probiotic bacterium, and acnegenic bacteria is unclear. This study examined the effects of L. reuteri on the proliferation of P. acnes and S. epidermidis. Human-derived L. reuteri strains (KCTC 3594 and KCTC 3678) and rat-derived L. reuteri KCTC 3679 were used. All strains exhibited significant inhibitory effects on the growth of P. acnes and S. epidermidis. The proliferation of P. acnes was decreased by 2-log scales after incubation with L. reuteri for 24 h. In addition, the proliferation of S. epidermidis was decreased by 3-log scales after incubation with L. reuteri for 24 h, whereas the growth of L. reuteri was unaffected by P. acnes or S. epidermidis. Among the L. reuteri strains examined, L. reuteri KCTC 3679 had the strongest inhibitory effect on the growth of P. acnes and S. epidermidis, followed by L. reuteri KCTC 3594 and L. reuteri KCTC 3678. Interestingly, reuterin, an antimicrobial factor, was produced only by L. reuteri KCTC 3594. The most pronounced the antibacterial activities of L. reuteri were attributed to the production of organic acids. Overall, these results suggest that L. reuteri may be a useful probiotic agent to control the growth of bacteria involved in acne inflammation and prevent acne.

Citing Articles

Modulations of the skin microbiome in skin disorders: A narrative review from a wound care perspective.

Piazzesi A, Scanu M, Ciprandi G, Putignani L Int Wound J. 2024; 21(10):e70087.

PMID: 39379177 PMC: 11461044. DOI: 10.1111/iwj.70087.

Potential of IDCC 4301 isolated from breast milk-fed infant feces as a probiotic and functional ingredient.

Ban O, Bang W, Jeon H, Jung Y, Yang J, Kim D Food Sci Nutr. 2023; 11(4):1952-1964.

PMID: 37051343 PMC: 10084967. DOI: 10.1002/fsn3.3230.

Host Microbiota Balance in Teenagers with Gum Hypertrophy Concomitant with Acne Vulgaris: Role of Oral Hygiene Associated with Topical Probiotics.

Mosaico G, Artuso G, Pinna M, Denotti G, Orru G, Casu C Microorganisms. 2022; 10(7).

PMID: 35889063 PMC: 9323849. DOI: 10.3390/microorganisms10071344.

Explore the Anti-Acne Mechanism of Licorice Flavonoids Based on Metabonomics and Microbiome.

Ruan S, Hu Y, Wu W, Du Q, Wang Z, Chen T Front Pharmacol. 2022; 13:832088.

PMID: 35211023 PMC: 8861462. DOI: 10.3389/fphar.2022.832088.

Microbiome Modulation as a Therapeutic Approach in Chronic Skin Diseases.

Polak K, Jobbagy A, Muszynski T, Wojciechowska K, Fratczak A, Banvolgyi A Biomedicines. 2021; 9(10).

PMID: 34680552 PMC: 8533290. DOI: 10.3390/biomedicines9101436.

References

Meisler D, Mandelbaum S . Propionibacterium-associated endophthalmitis after extracapsular cataract extraction. Review of reported cases. Ophthalmology. 1989; 96(1):54-61. DOI: 10.1016/s0161-6420(89)32939-3. View

Spinler J, Taweechotipatr M, Rognerud C, Ou C, Tumwasorn S, Versalovic J . Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008; 14(3):166-71. PMC: 2494590. DOI: 10.1016/j.anaerobe.2008.02.001. View

Taniguchi M, Nakazawa H, Takeda O, Kaneko T, Hoshino K, Tanaka T . Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longum and Propionibacterium freudenreichii. Biosci Biotechnol Biochem. 1998; 62(8):1522-7. DOI: 10.1271/bbb.62.1522. View

Ochsendorf F . Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges. 2006; 4(10):828-41. DOI: 10.1111/j.1610-0387.2006.06053.x. View

Koreck A, Pivarcsi A, Dobozy A, Kemeny L . The role of innate immunity in the pathogenesis of acne. Dermatology. 2003; 206(2):96-105. DOI: 10.1159/000068476. View

GUIN J, Huber D, Gielerak P . Antibiotic sensitivity of comedonal Propionibacterium acnes. Acta Derm Venereol. 1979; 59(6):552-54. View

Breathnach A, Passi S . Azelaic acid. Br J Dermatol. 1984; 111(1):115-20. DOI: 10.1111/j.1365-2133.1984.tb04025.x. View

Johnson M, Johnson K, Engel A . Prevalence, morbidity, and cost of dermatologic diseases. J Am Acad Dermatol. 1984; 11(5 Pt 2):930-6. DOI: 10.1016/s0190-9622(84)80017-1. View

Zouboulis C, Piquero-Martin J . Update and future of systemic acne treatment. Dermatology. 2003; 206(1):37-53. DOI: 10.1159/000067821. View

10.

Gill H, Shu Q, Lin H, Rutherfurd K, Cross M . Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol. 2002; 190(3):97-104. DOI: 10.1007/s004300100095. View

11.

Cleusix V, Lacroix C, Vollenweider S, Duboux M, Le Blay G . Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 2007; 7:101. PMC: 2222629. DOI: 10.1186/1471-2180-7-101. View

12.

Cogen A, Nizet V, Gallo R . Skin microbiota: a source of disease or defence?. Br J Dermatol. 2008; 158(3):442-55. PMC: 2746716. DOI: 10.1111/j.1365-2133.2008.08437.x. View

13.

Caglar E, Cildir S, Ergeneli S, Sandalli N, Twetman S . Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand. 2006; 64(5):314-8. DOI: 10.1080/00016350600801709. View

14.

Leyden J . Therapy for acne vulgaris. N Engl J Med. 1997; 336(16):1156-62. DOI: 10.1056/NEJM199704173361607. View

15.

Nam C, Kim S, Sim Y, Chang I . Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents. Skin Pharmacol Appl Skin Physiol. 2003; 16(2):84-90. DOI: 10.1159/000069030. View

16.

Slininger P, Bothast R, SMILEY K . Production of 3-hydroxypropionaldehyde from glycerol. Appl Environ Microbiol. 1983; 46(1):62-7. PMC: 239268. DOI: 10.1128/aem.46.1.62-67.1983. View

17.

Kang M, Oh J, Lee H, Lim H, Lee S, Yang K . Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J Microbiol. 2011; 49(2):193-9. DOI: 10.1007/s12275-011-0252-9. View

18.

Nikawa H, Makihira S, Fukushima H, Nishimura H, Ozaki Y, Ishida K . Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int J Food Microbiol. 2004; 95(2):219-23. DOI: 10.1016/j.ijfoodmicro.2004.03.006. View

19.

Webster G, Leyden J, Tsai C, Baehni P, McArthur W . Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol. 1980; 74(6):398-401. DOI: 10.1111/1523-1747.ep12544494. View

20.

Patel M, Bowe W, Heughebaert C, Shalita A . The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J Drugs Dermatol. 2010; 9(6):655-64. View